Macrophage migration inhibitory factor (MIF): a Janus-faced cytokine in viral pathogenesis and host defense

Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect. 2010;23(4):257.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sumaiya K, Langford D, Natarajaseenivasan K, Shanmughapriya S. Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol Ther. 2022;233:108024. https://doi.org/10.1016/j.pharmthera.2021.108024.

Article  PubMed  CAS  Google Scholar 

Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800. https://doi.org/10.1038/nri1200.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 2009;583(17):2749–57.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Weber C, Kraemer S, Drechsler M, Lue H, Koenen RR, Kapurniotu A, et al. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment. Proc Natl Acad Sci U S A. 2008;105(42):16278–83. https://doi.org/10.1073/pnas.0804017105.

Article  PubMed  PubMed Central  Google Scholar 

Klasen C, Ohl K, Sternkopf M, Shachar I, Schmitz C, Heussen N, et al. MIF promotes B cell chemotaxis through the receptors CXCR4 and CD74 and ZAP-70 signaling. J Immunol. 2014;192(11):5273–84.

Article  PubMed  CAS  Google Scholar 

Regis EG, Barreto-de-Souza V, Morgado MG, Bozza MT, Leng L, Bucala R, et al. Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication. Virology. 2010;399(1):31–8.

Article  PubMed  CAS  Google Scholar 

Xu R, Wu Y, Xiang X, Lv X, He M, Xu C, et al. Sulforaphane effectively inhibits HBV by altering Treg/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo. Virus Res. 2024;341:199316. https://doi.org/10.1016/j.virusres.2024.199316.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang S, Lin R, Zhou Z, Wen S, Lin L, Chen S, et al. Macrophage migration inhibitory factor interacts with HBx and inhibits its apoptotic activity. Biochem Biophys Res Commun. 2006;342(2):671–9. https://doi.org/10.1016/j.bbrc.2006.01.180.

Article  PubMed  CAS  Google Scholar 

Zhang L, Nan X, Zhou D, Wang X, Zhu S, Li Q, et al. Japanese encephalitis virus NS1 and NS1’ protein disrupts the blood-brain barrier through macrophage migration inhibitory factor-mediated autophagy. J Virol. 2024;98(5):e0011624. https://doi.org/10.1128/jvi.00116-24.

Article  PubMed  CAS  Google Scholar 

Trifone C, Baquero L, Czernikier A, Benencio P, Leng L, Laufer N, et al. Macrophage migration inhibitory factor (MIF) promotes increased proportions of the highly permissive Th17-like cell profile during HIV infection. Viruses. 2022. https://doi.org/10.3390/v14102218.

Article  PubMed  PubMed Central  Google Scholar 

Cheng J-Y, Shan G-Y, Wan H, Zhang Y-X, Gao Z-C, Shi Y-P, et al. Mif/CD74 axis in hepatic stellate cells mediates HBV-related liver fibrosis. Int Immunopharmacol. 2025;147:113929. https://doi.org/10.1016/j.intimp.2024.113929.

Article  PubMed  CAS  Google Scholar 

Zhang L, Nan X, Zhou D, Wang X, Zhu S, Li Q, et al. Japanese encephalitis virus NS1 and NS1′ protein disrupts the blood-brain barrier through macrophage migration inhibitory factor-mediated autophagy. J Virol. 2024;98(5):e00116-e124.

Article  PubMed  PubMed Central  Google Scholar 

Smith CA, Tyrell DJ, Kulkarni UA, Wood S, Leng L, Zemans RL, et al. Macrophage migration inhibitory factor enhances influenza-associated mortality in mice. JCI Insight. 2019;4(13):e128034.

Article  PubMed  PubMed Central  Google Scholar 

Chuang Y-C, Lei H-Y, Liu H-S, Lin Y-S, Fu T-F, Yeh T-M. Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine. 2011;54(2):222–31.

Article  PubMed  CAS  Google Scholar 

Trifone C, Baquero L, Czernikier A, Benencio P, Leng L, Laufer N, et al. Macrophage migration inhibitory factor (MIF) promotes increased proportions of the highly permissive Th17-like cell profile during HIV infection. Viruses. 2022;14(10):2218.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Delaloye J, De Bruin IJ, Darling KE, Reymond MK, Sweep FC, Roger T, et al. Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection. Cytokine. 2012;60(2):338–40.

Article  PubMed  CAS  Google Scholar 

Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res. 2000;20(9):751–62.

Article  PubMed  CAS  Google Scholar 

Mitchell RA, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002;99(1):345–50.

Article  PubMed  CAS  Google Scholar 

Thiele M, Donnelly SC, Mitchell RA. OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases. J Immunother Cancer. 2022;10(9):e005475. https://doi.org/10.1136/jitc-2022-005475.

Article  PubMed  PubMed Central  Google Scholar 

Noe JT, Mitchell RA. MIF-dependent control of tumor immunity. Front Immunol. 2020. https://doi.org/10.3389/fimmu.2020.609948.

Article  PubMed  PubMed Central  Google Scholar 

Su Y, Wang Y, Zhou Y, Zhu Z, Zhang Q, Zhang X, et al. Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor. Oncotarget. 2016. https://doi.org/10.18632/oncotarget.13739.

Article  PubMed  PubMed Central  Google Scholar 

Rajasekaran D, Gröning S, Schmitz C, Zierow S, Drucker N, Bakou M, et al. Macrophage migration inhibitory factor-CXCR4 receptor interactions: evidence for partial allosteric agonism in comparison with cxcl12 chemokine. J Biol Chem. 2016;291(30):15881–95. https://doi.org/10.1074/jbc.M116.717751.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kontos C, El Bounkari O, Krammer C, Sinitski D, Hille K, Zan C, et al. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting. Nat Commun. 2020;11(1):5981. https://doi.org/10.1038/s41467-020-19764-z.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kraemer S, Lue H, Zernecke A, Kapurniotu A, Andreetto E, Frank R, et al. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism. FASEB J. 2011;25(3):894–906. https://doi.org/10.1096/fj.10-168559.

Article  PubMed  CAS  Google Scholar 

Jäger B, Klatt D, Plappert L, Golpon H, Lienenklaus S, Barbosa PD, et al. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer. Cell Signal. 2020;73:109672. https://doi.org/10.1016/j.cellsig.2020.109672.

Article  PubMed  CAS  Google Scholar 

Spiller L, Zhang L, Gerra S, Stoppe C, Scheiermann P, Calandra T, et al. In vivo synergistic enhancement of MIF-mediated inflammation in acute lung injury by the plant ortholog Arabidopsis MDL1. FASEB J. 2025;39(6):e70489. https://doi.org/10.1096/fj.202403301R.

Article  PubMed  CAS  Google Scholar 

Comments (0)

No login
gif